Why the study?
Does nicorandil infused into the pulmonary artery alter hemodynamic parameters in patients with coronary artery disease and normal controls?
Does nicorandil infused into the pulmonary artery alter hemodynamic parameters in patients with coronary artery disease and normal controls?
Nicorandil infusion into the pulmonary artery produces a sustained reduction in preload and a transient reduction in afterload, with additive effects in patients already on antianginal medication.
Answers are grounded in this paper and cite their sources.
May support pulmonary artery nicorandil for sustained preload reduction in CAD; leaves open randomized confirmation of clinical benefit.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: